Study of Sumatriptan Naproxen Sodium Succinate Tablets for the Treatment of Acute Migraine Attacks
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
A multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the
efficacy and safety of sumatriptan naproxen sodium succinate tablets in the treatment of
acute migraine attacks.
Phase:
Phase 3
Details
Lead Sponsor:
Peking University Third Hospital
Collaborators:
Beijing Friendship Hospital Jiangsu Provincial People's Hospital Second Affiliated Hospital of Wenzhou Medical University Second Hospital of Jilin University The Affiliated Hospital of Qingdao University The First Affiliated Hospital of Guangzhou Medical University The Second Affiliated Hospital of Kunming Medical University The Second Hospital of Nanjing Medical University The Third Xiangya Hospital of Central South University West China Hospital